Search
for
Sort by
Research 301–330 of 730
- Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial
- Effects of Short-Term Finasteride on Apoptotic Factors and Androgen Receptors in Prostate Cancer Cells
- Risk Factors for Male Lower Urinary Tract Symptoms: The Role of Metabolic Syndrome and Androgenetic Alopecia in a Latin American Population
- Laser-assisted Hair Regrowth
- Hair, Hormones, and High-Risk Prostate Cancer
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Subject Index
- 1407 ANDROGENETIC ALOPECIA, PROSTATE VOLUME AND URINARY SYMPTOMS. IS THERE A RELATIONSHIP? A CASE-CONTROL STUDY
- Male breast cancer after finasteride therapy for benign prostate hyperplasia
- Associations between semen quality and lower urinary tract symptoms in ageing male
- Anti-Androgen Effects of Extracts and Compounds from<i>Ganoderma lucidum</i>
- Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Hair Loss in Women
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Guidelines for the management of androgenetic alopecia (2010)
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Evaluation of New Pregnane Derivatives as 5.ALPHA.-Reductase Inhibitor.
- Molecular Interactions of New Pregnenedione Derivatives
- Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
- Feasibility of implementing current best clinical practice for people who are using anabolic androgenic steroids within a Swiss primary care practice: a quality assurance study
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Should Finasteride Be Routinely Given Preoperatively for TURP?
- A Review: Proteins Involved in the Major Symptoms of Polycystic Ovarian Syndrome
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Redefining hormone resistance in prostate cancer